Bioethics Stock Net Income
| BOTH Stock | USD 0.01 0.00 0.00% |
As of the 9th of February, Bioethics shows the Standard Deviation of 12.26, risk adjusted performance of (0.09), and Mean Deviation of 2.97. Bioethics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Bioethics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Bioethics' valuation are provided below:Bioethics does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Bioethics |
Bioethics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bioethics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bioethics.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in Bioethics on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Bioethics or generate 0.0% return on investment in Bioethics over 90 days. It intends to seek, investigate, and if warranted acquire an interest in a business opportunity More
Bioethics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bioethics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bioethics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 99.59 |
Bioethics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioethics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bioethics' standard deviation. In reality, there are many statistical measures that can use Bioethics historical prices to predict the future Bioethics' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.31) | |||
| Total Risk Alpha | (2.73) | |||
| Treynor Ratio | 0.5899 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bioethics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bioethics February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | 0.5999 | |||
| Mean Deviation | 2.97 | |||
| Coefficient Of Variation | (812.40) | |||
| Standard Deviation | 12.26 | |||
| Variance | 150.28 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (1.31) | |||
| Total Risk Alpha | (2.73) | |||
| Treynor Ratio | 0.5899 | |||
| Maximum Drawdown | 99.59 | |||
| Skewness | (8.12) | |||
| Kurtosis | 66.0 |
Bioethics Backtested Returns
Bioethics secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of risk over the last 3 months. Bioethics exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bioethics' Risk Adjusted Performance of (0.09), standard deviation of 12.26, and Mean Deviation of 2.97 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -2.58, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bioethics are expected to decrease by larger amounts. On the other hand, during market turmoil, Bioethics is expected to outperform it. At this point, Bioethics has a negative expected return of -1.58%. Please make sure to confirm Bioethics' variance and kurtosis , to decide if Bioethics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Bioethics has no correlation between past and present. Overlapping area represents the amount of predictability between Bioethics time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bioethics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Bioethics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.64 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Bioethics reported net income of (107,183). This is 100.01% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The net income for all United States stocks is 100.02% higher than that of the company.
Bioethics Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bioethics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bioethics could also be used in its relative valuation, which is a method of valuing Bioethics by comparing valuation metrics of similar companies.Bioethics is currently under evaluation in net income category among its peers.
Bioethics Fundamentals
| Return On Asset | -56.39 | |||
| Current Valuation | 647.72 K | |||
| Shares Outstanding | 1.14 M | |||
| Shares Owned By Insiders | 88.53 % | |||
| Price To Book | 2,021 X | |||
| EBITDA | (59.14 K) | |||
| Net Income | (107.18 K) | |||
| Cash And Equivalents | 554 | |||
| Total Debt | 398.53 K | |||
| Book Value Per Share | (0.58) X | |||
| Cash Flow From Operations | (27.48 K) | |||
| Earnings Per Share | (0.09) X | |||
| Beta | 0.53 | |||
| Market Capitalization | 295.15 K | |||
| Total Asset | 734 | |||
| Net Asset | 734 |
About Bioethics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioethics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioethics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioethics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Bioethics Pink Sheet
Bioethics financial ratios help investors to determine whether Bioethics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioethics with respect to the benefits of owning Bioethics security.